ADC Therapeutics (ADCT) Insider Trading & Ownership $3.14 -0.08 (-2.48%) (As of 10/17/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ADC Therapeutics (NYSE:ADCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.05%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$1.12 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$153,410.43 Get ADCT Insider Trade Alerts Want to know when executives and insiders are buying or selling ADC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADCT Insider Buying and Selling by Quarter Ad DarwinUnlock the Secret to Earning Consistent Income from Stocks Under $30!Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE!👉 Yes, I Want the Free Report! 👈 ADC Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/1/2024Redmile Group, LlcMajor ShareholderBuy400,000$2.81$1,124,000.00 6/17/2024Robert AzelbyDirectorSell6,995$2.89$20,215.55 5/7/2024Ameet MallikCEOSell29,731$4.48$133,194.88 (Data available from 1/1/2013 forward) ADCT Insider Trading Activity - Frequently Asked Questions Who is on ADC Therapeutics's Insider Roster? The list of insiders at ADC Therapeutics includes Ameet Mallik, Redmile Group, Llc, and Robert Azelby. Learn more on insiders at ADCT. What percentage of ADC Therapeutics stock is owned by insiders? 4.05% of ADC Therapeutics stock is owned by insiders. Learn more on ADCT's insider holdings. Which ADC Therapeutics insiders have been buying company stock? The following insider purchased ADCT shares in the last 24 months: Redmile Group, Llc ($1,124,000.00). How much insider buying is happening at ADC Therapeutics? Insiders have purchased a total of 400,000 ADCT shares in the last 24 months for a total of $1,124,000.00 bought. Which ADC Therapeutics insiders have been selling company stock? The following insiders have sold ADCT shares in the last 24 months: Ameet Mallik ($133,194.88), and Robert Azelby ($20,215.55). How much insider selling is happening at ADC Therapeutics? Insiders have sold a total of 36,726 ADC Therapeutics shares in the last 24 months for a total of $153,410.43 sold. More Insider Trading Tools from MarketBeat Related Companies: MRSN Insider Selling NKTR Insider Selling ITOS Insider Selling CCCC Insider Selling VERV Insider Selling ALEC Insider Selling CTMX Insider Selling PCRX Insider Selling OPK Insider Selling WVE Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major UpsideInsiders Hold Tight as Helen of Troy Prepares for a Major ReboundInsiders Are Betting Big on These 2 StocksThis Is the Top Large-Cap Stock Insiders Are Buying This page (NYSE:ADCT) was last updated on 10/17/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredRetire off just one stock ticker?ONE AI Stock is All You Need... There are over 6,000 stocks listed in the market right now. They will NOT m...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADC Therapeutics SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ADC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
